Orforglipron
Anti-obesity medication
Orforglipron
Orforglipron, sold under the brand name Foundayo, is a medication used for weight management. It is an oral, non-peptide, small-molecule GLP-1 receptor agonist developed as a weight loss drug by Eli Lilly and Company. It was discovered by Chugai Pharmaceutical Co., then was licensed to Lilly in 2018. Orforglipron was approved for medical use in the United States in April 2026. It was approved for use in the UK in August 2026.
Read on Wikipedia · Image Vaccinationist, CC BY-SA 4.0
Open boosters, collect cards and trade them. Free to play.
Play for free